Periodontitis and inflammatory markers in transplant recipients

Journal of Periodontology

Volumn 81, Issue 5, 2010, Pages 666-672

  Shaqman, Murad ^a   Ioannidou, Effie ^a   Burleson, Joseph ^a   Hull, David ^b   Dongari Bagtzoglou, Anna ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

C reactive protein; Chronic periodontitis; Inflammation; Interleukin 6; Organ transplant

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6;

AGE; ARTICLE; BLOOD; BODY MASS; CADAVER; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DONOR; FEMALE; GINGIVA BLEEDING; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET;

AGE FACTORS; BODY MASS INDEX; C-REACTIVE PROTEIN; CADAVER; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; GINGIVAL HEMORRHAGE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; TISSUE DONORS;

EID: 77952087285     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.090570     Document Type: Article

References (39)

1. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
2. Kinane DF, Lappin DF. Immune processes in periodontal disease: A review. Ann Periodontol 2002;7: 62-71.
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801. (erratum 2006;116:2308).
4. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998;69:899-910.
5. Takahashi K, Takashiba S, Nagai A, et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease. J Periodontol 1994;65:147-153.
6. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35: 277-290.
7. O'Connell PA, Taba M, Nomizo A, et al. Effects of periodontal therapy on glycemic control and inflammatory markers. J Periodontol 2008;79:774-783.
8. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-920.
9. Health Resources and Services Administration. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville, MD: U.S. Department of Health and Human Services; 2007.
10. Yates PJ, Nicholson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol 2006;16:148-157.
11. Ramzy D, Rao V, Brahm J, Miriuka S, Delgado D, Ross HJ. Cardiac allograft vasculopathy: A review. Can J Surg 2005;48:319-327.
12. Hartono C, Dadhania D, Suthanthiran M. Noninvasive diagnosis of acute rejection of solid organ transplants. Front Biosci 2004;9:145-153.
13. Raasveld MH, Bloemena E, Wilmink JM, Surachno S, Schellekens PT, ten Berge RJ. Interleukin-6 and neopterin in renal transplant recipients: A longitudinal study. Transpl Int 1993;6:89-94.
14. Van Oers MH, Van der Heyden AA, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988;71: 314-319.
15. van Ree RM, Oterdoom LH, de Vries AP, et al. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant 2007; 22:246-253.
16. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78(Suppl. 7):1387-1399.
17. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
18. Papapanou PN. Periodontal diseases: Epidemiology. Ann Periodontol 1996;1:1-36.
19. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: Findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000;71:743-751.
20. Leung WK, Yau JY, Jin LJ, et al. Subgingival microbiota of renal transplant recipients. Oral Microbiol Immunol 2003;18:37-44.
21. Lessem J, Drisko C, Greenwell H, et al. Are cardiac transplant patients more likely to have periodontitis? A case record study. J Int Acad Periodontol 2002;4: 95-100.
22. Oshrain HI, Telsey B, Mandel ID. A longitudinal study of periodontal disease in patients with reduced immunocapacity. J Periodontol 1983;54:151-154.
23. Rahman MM, Caglayan F, Rahman B. Periodontal health parameters in patients with chronic renal failure and renal transplants receiving immunosuppressive therapy. J Nihon Univ Sch Dent 1992;34: 265-272.
24. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-273.
25. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
26. Allan JS, Madsen JC. Recent advances in the immunology of chronic rejection. Curr Opin Nephrol Hypertens 2002;11:315-321.
27. Nocera A, Tagliamacco A, De Palma R, et al. Cytokine mRNA expression in chronically rejected human renal allografts. Clin Transplant 2004;18:564-570.
28. Cottone S, Palermo A, Vaccaro F, et al. In renal transplanted patients inflammation and oxidative stress are interrelated. Transplant Proc 2006;38: 1026-1030. (Pubitemid 43833230)
29. Ioannidou E, Kao D, Chang N, Burleson J, Dongari- Bagtzoglou A. Elevated serum interleukin-6 (IL-6) in solid-organ transplant recipients is positively associated with tissue destruction and IL-6 gene expression in the periodontium. J Periodontol 2006;77:1871-1878.
30. Van Snick J. Interleukin-6: An overview. Annu Rev Immunol 1990;8:253-278.
31. Cainelli F, Vento S. Infections and solid organ transplant rejection: A cause-and-effect relationship? Lancet Infect Dis 2002;2:539-549.
32. Waiser J, Budde K, Katalinic A, Kuerzdörfer M, Riess R, Neumayer HH. Interleukin-6 expression after renal transplantation. Nephrol Dial Transplant 1997;12: 753-759.
33. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128: 127-137.
34. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005;183: 308-315.
35. Herder C, Schneitler S, Rathmann W, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 2007;92:4569-4574.
36. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823.
37. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12.
38. Morales-Indiano C, Lauzurica R, Pastor MC, et al. Greater posttransplant inflammation and oxidation are associated with worsening kidney function in patients with pretransplant diabetes mellitus. Transplant Proc 2009;41:2126-2128.
39. Ghobrial RM, Gornbein J, Steadman R, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002;236:315-322; discussion 322-1313